See Appendix S1.
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen
Article first published online: 23 MAR 2014
© 2014 British HIV Association
Volume 15, Issue 9, pages 547–556, October 2014
How to Cite
Jarrin, I., Hernández-Novoa, B., Alejos, B., Santos, I., Lopez-Aldeguer, J., Riera, M., Gutiérrez, F., Rubio, R., Antela, A., Blanco, J., Moreno, S. and the Cohort of the Spanish HIV Research Network (CoRIS) (2014), Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen. HIV Medicine, 15: 547–556. doi: 10.1111/hiv.12144
- Issue published online: 17 SEP 2014
- Article first published online: 23 MAR 2014
- Manuscript Accepted: 29 JAN 2014
- Instituto de Salud Carlos III through the Red Temática de Investigación Cooperativa en SIDA. Grant Numbers: RD06/006, RD12/0017
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.